The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • No ClinVar Id was directly found from the curated document
  • No CSPEC related information was provided by the message!

  • No Criteria Specification was provided in the publication event for the variant classifaction.
  • The Criteria Specification shown below is a best-estimate based on the VCEP, gene, disease, and publication date.

Variant: NM_001142805.2:c.1426C>T

CA415087684

Gene: SLC6A8 (HGNC:6535)
Condition: creatine transporter deficiency (MONDO:0010305)
Inheritance Mode: X-linked inheritance
UUID: ffff00ed-7b84-47f8-b970-fb01172a5121
Approved on: 2023-08-07
Published on: 2023-08-24

HGVS expressions

NM_001142805.2:c.1426C>T
NC_000023.11:g.153694407C>T
CM000685.2:g.153694407C>T
NC_000023.10:g.152959862C>T
CM000685.1:g.152959862C>T
NC_000023.9:g.152613056C>T
NG_012016.1:g.11111C>T
NG_012016.2:g.11111C>T
ENST00000253122.10:c.1456C>T
ENST00000253122.9:c.1456C>T
ENST00000413787.1:c.385C>T
ENST00000430077.6:c.1111C>T
ENST00000442457.1:c.510C>T
ENST00000485324.1:n.1677C>T
NM_001142805.1:c.1426C>T
NM_001142806.1:c.1111C>T
NM_005629.3:c.1456C>T
NM_005629.4:c.1456C>T
More

Pathogenic

Met criteria codes 3
PP4_Strong PM2_Supporting PVS1
Not Met criteria codes 2
PP1 PS4

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specifications for this VCEP
Evidence submitted by expert panel
Cerebral Creatine Deficiency Syndromes VCEP
The NM_005629.4:c.1456C>T (p.Gln486Ter) variant in SLC6A8 is a nonsense variant predicted to cause a premature stop codon in biologically relevant exon 10/13 leading to nonsense mediated decay in a gene in which loss-of-function is an established disease mechanism (PVS1). This variant has been reported in two monozygotic male twins with developmental delay, elevated urine creatine/creatinine, and absent creatine peak on brain MRS (PMID: 22196490) and was inherited from their mother, who had intellectual disability (PP4_Strong). The variant is absent in gnomAD v2.1.1. (PM2_Supporting). There is no ClinVar entry for this variant. In summary, this variant meets criteria to be classified as pathogenic for creatine transporter deficiency. SLC6A8-specific criteria applied, as specified by the ClinGen CCDS VCEP (Specifications Version 1.1.0): PVS1, PP4_Strong, PM2_Supporting. (Classification approved by the ClinGen CCDS VCEP, August 7, 2023)
Met criteria codes
PP4_Strong
PMID: 22196490: male twins had 'urinary creatine/creatinine ratio was increased (2.24 and 1.84, respectively; normal range, 0.04-0.56), with a normal level of guanidinoacetic acid (42 and 40 μmol/mmol creatinine, respectively; normal range, 18-130 μmol/mmol creatinine) and a low level of creatinine plasma (2.2 and 1.84 mmol/L, respectively; normal range, 5-19.5 mmol/L)' and absent creatine peak on brain MRS
PM2_Supporting
The variant is absent in gnomAD v2.1.1. (PM2_Supporting).
PVS1
The NM_005629.4:c.1456C>T (p.Gln486Ter) variant in SLC6A8 is a nonsense variant predicted to cause a premature stop codon in biologically relevant exon 10/13 leading to nonsense mediated decay in a gene in which loss-of-function is an established disease mechanism (PVS1).
Not Met criteria codes
PP1
PMID: 22196490: 2 affected male monozygotic twins, inherited from het mom who had ID (1 aff seg)
PS4
PMID: 22196490: 2 affected male monozygotic twins, inherited from het mom who had ID (1 aff seg); not counted for PS4 b/c counted for PP4
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
ClinGen Terms of Use.
¤ Powered by BCM's Genboree.